Hepatitis B viruses and cancerogenesis

Biomedicine and Pharmacotherapy

Volumn 52, Issue 1, 1998, Pages 34-43

  Buendia, M A ^a  

^a INSERM   (France)

Author keywords

Hepadnavirus; Hepatocellular carcinoma; Liver

Indexed keywords

APOPTOSIS; CARCINOGENICITY; CELL PROLIFERATION; DISEASE ASSOCIATION; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; PRIORITY JOURNAL; REVIEW; VIRUS CARCINOGENESIS; VIRUS CELL INTERACTION; VIRUS GENOME; VIRUS REPLICATION;

EID: 0031910239     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0753-3322(97)86239-7     Document Type: Article

References (83)

1. 1 IARC. Hepatitis Viruses. Monographs on the Evaluation of Carcinogenic Risks. Lyon, France. 1994
2. 2 Johnson PJ. Hepatitis B virus and primary liver cancer. In : Bréchet C, ed. Primary Liver Cancer : Etiological and Progression Factors. Boca Raton: CRC Press; 1994. p 31-40
3. 3 Hollinger FB. Hepatitis B virus. In : Fields BN, Knipe, DM. Howley, PM, eds. Fields Virologv. 3rd ed Philadelphia : Lippincott-Raven : 1996. p 2738-808
4. 4 Szmuness W. Hepatocellular carcinoma and the hepatitis B virus : evidence for a causal association. Prog Med Virol 1978 ; 24 : 40-69
5. 5 Beasley RP, Lin CC, Hwang LY, Chien CS. Hepatocellular carcinoma and hepatitis B virus : a prospective study of 22,707 men in Taiwan. Lancet 1981 ; 2 : 1129-33
6. 6 Chang MH, Chen CJ, Lai MS, Hsu MH, Wu TC et al. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. N Engl J Med 1997 ; 336 : 1855-9
7. 7 Chen HS, Kanako S, Girones R, Anderson RW, Hornbuckle WE, Tennant BC et al. The woodchuck hepatitis virus X gene is important for establishment of virus infection in woodchucks. J Virol 1993 ; 67 : 1218-26
8. 8 Zoulim F, Saputelli J, Seeger C. Woodchuck hepatitis virus X protein is required for viral infection in vivo. J Virol 1994 ; 68 : 2026-30
9. 9 Yen BTS. Hepadnaviral X protein : review of recent progress. J Biomed Sci 1996 ; 3 : 20-30
10. 10 Summers J, Smolec JM, Snyder R. A virus similar to human hepatitis B virus associated with hepatitis and hepatoma in woodchucks. Proc Natl Acad Sci USA 1978 ; 75 : 4533-7
11. 11 Marion PL, Oshiro LS, Regnery DC, Scullard GH, Robinson WS. A virus in becchey ground squirrels that is related to hepatitis B virus of humans. Proc Natl Acad Sci USA 1980 ; 77 : 2941-5
12. 12 Testut P, Renard CA, Terradillos O, Vitvitski-Trépo L, Tekaia F, Degott C et al. A new hepadnavirus endemic in arctic ground squirrels in Alaska. J Virol 1996 ; 70 : 4210-19
13. 13 Mason WS, Seal G, Summers J. Virus of Pekin ducks with structural and biological relatedness to human hepatitis B virus. J Virol 1980 ; 36 : 829-36
14. 14 Sprengel R, Kaleta EF, Will H. Isolation and characterization of a hepatitis B virus endemic in herons. J Virol 1988 ; 62 : 3832-9
15. 15 Summers J, Mason WS. Replication of the genome of a hepatitis B-like virus by reverse transcription of an RNA intermediate. Cell 1982 ; 29 : 403-15
16. 16 Fourel G, Tiollais P. Molecular biology of hepatitis B virus. In :Bréchot C, ed. Primary Liver Cancer : Etiological and Progression Factors. Boca Raton : CRC Press; 1994. p 89-124
17. 17 Ganem D. Hepadnaviridae : the viruses and their replication. In : Fields B, Knipe, D, Howley, P eds. Fields Virology. Philadelphia: Lippincott-Raven ; 1996. p 2703-37
18. 18 Ferrari C, Penna A, Bertoletti A, Valli A, Flaccadori F. Immunopathogenetic aspects of hepatitis B virus infection. In : Bréchot C ed. Primary Liver Cancer : Etiological and Progression Factors. Boca Raton: CRC Press: 1994. p 137-47
19. 19 Chisari FV. Immanobiology and pathogenesis of viral hepatitis. In : Rizetto M, Purcell RH, Gerin JL Verme, G. eds. Viral Hepatitis and Liver Disease. Torino : Edizioni Minerva Medica ; 1997. p 405-15
20. 20 Kim CM, Koike K., Saito I, Miyamura T, Jay G. HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature 1991 ; 351 : 317-20
21. 21 Chisari FV, Klopchin K, Moriyama T, Pasquinelli C, Dunsford HA, Sell S et al. Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice. Cell 1989 ; 59 : 1145-56
22. 22 Caselmann WH, Meyer M, Kekulé AS, Lauer U, Hofschneider PH, Koshy R. A trans-activator function is generated by integration of hepatitis B virus pre-S/S sequences in human hepatocellular carcinoma DNA. Proc Natl Acad Sci USA 1990 ; 87 : 2970-4
23. 23 Kekulé AS, Lauer U, Meyer M, Caselmann WH, Hofschneider PH, Koshy R. The pre-S2/S region of integrated hepatitis B virus DNA encodes a transcriptional transactivator. Nature 1990 ; 343 : 457-61
24. 24 Bréchot C, Pourcel C, Louise A, Rain B, Tiollais P. Presence of integrated hepatitis B virus DNA sequences in cellular DNA of human hepatocellular carcinoma. Nature 1980 ; 286 : 533-5
25. 25 Matsubara K, Tokino T. Integration of hepatitis B virus DNA and its implications for hepatocarcinogenesis. Mol Biol Med 1990 ; 7 : 243-60
26. 26 Dejean A, Bougueleret L, Grzeschik KH, Tiollais P. Hepatitis B virus DNA integration in a sequence homologous to v-erbA and steroid receptor genes in a hepatocellular carcinoma. Nature 1986 ; 322 : 70-2
27. 27 De Thé H, Marchio A, Tiollais P, Dejean A. A novel steroid/thyroid hormone receptor-related gene inappropriately expressed in human hepatocellular carcinoma. Nature 1987 ; 330 : 667-70
28. 28 Wang J, Chenivesse X, Henglein B, Bréchot C. Hepatitis B virus integration in a cyclin A gene in a human hepatocellular carcinoma. Nature 1990 ; 343 : 555-7
29. 29 Saigo K, Chumi M, Poussin K, Clepet C, Gyapay J, Caudron B et al. Conference abstract. Molecular Biology of Hepatitis B viruses. Paris, France, 1997
30. 30 Graef E, Caselmann WH, Wells J, Koshy R. Insertional activation of mevalonate kinase by hepatitis B virus DNA in a human hepatoma cell line. Oncogene 1994 ; 9 : 81-7
31. 31 Hsu TY, Möröy T, Etiemble J, Louise A, Trépo C, Tiollais P et al. Activation of c-myc by woodchuck hepatitis virus insertion in hepatocellular carcinoma. Cell 1988 ; 55 : 627-35
32. 32 Fourel G, Trépo C, Bougueleret L, Henglein B, Ponzetto A, Tiollais P et al. Frequent activation of N-myc genes by hepadnavirus insertion in woodchuck liver tumours. Nature 1990 ; 347 : 294-8
33. 33 Fourel G, Couturier J, Wei Y, Apiou F, Tiollais P, Buendia MA. Evidence for long-range oncogene activation by hepadnavirus insertion. EMBO J 1994 ; 13 : 2526-34
34. 34 Flajolet M, Fourel G, Wei Y, Transy C, Renard CA, Tiollais P et al. Hepatocellular carcinoma in the woodchuck. In : Rizzetto M, Purcell RH, Gerin JL, Verme G, eds. Viral Hepatitis and Liver Disease. Torino : Edizioni Minerva Medica ; 1996. p 509-14
35. 35 Fourel G, Ringeisen F, Flajolet M, Tronche F, Pontoglio M, Tiollais P, Buendia MA. The HNF1/HNF4-dependent We2 element of woodchuck hepatitis virus controls viral replication and can activate the N-myc2 promoter, J Virol 1996 ; 70 : 8571-83
36. 36 Marchio A, Meddeb M, Pineau P, Danglot G, Tiollais P, Bernheim A et al. Recurrent chromosomal abnormalities in hepatocellular carcinoma detected by comparative genomic hybridization. Genes, Chromosomes and Cancer 1997 ; 18 : 59-65
37. 37 Nagai H, Pineau P, Tiollais P, Buendia MA, Dejean A. Comprehensive allelotyping of human hepatocellular carcinoma. Oncogene 1997 ; 14 : 2927-33
38. 38 Boige V, Laurent-Puig P, Fouchet P, Fléjou JF, Monges G, Bedossa P et al. Concerted nonsyntenic allelic losses in hyperploid hepatocellular carcinoma as determined by high-resolution allelotype. Cancer Res 1997 ; 57 : 1986-90
39. 39 Zhou YZ, Slagle BL, Donehower LA, vanTuinen P, Ledbetter DH, Butel JS. Structural analysis of a hepatitis B virus genome integrated into chromosome 17p of a human hepatocellular carcinoma. J Virol 1988 ; 62 : 4224-31
40. 40 Slagle BL, Zhou YZ, Butel JS. Hepatitis B virus integration event in human chromosome 17p near the p53 gene identifies the region of the chromosome commonly deleted in virus-positive hepatocellular carcinomas. Cancer Res 1991 ; 51 : 49-54
41. 41 Becker SA, Zhou YZ, Slagle BL. Frequent loss of chromosome 8p in hepatitis B-positive hepalocelluiar carcinomas from China. Cancer Res 1996 ; 56 : 5092-7
42. 42 Bressac B, Kew M, Wands J, Ozturk M. Selective G to T mutations of p53 gene in hepatocellular carcinoma from Southern Africa. Nature 1991 ; 350 : 429-31
43. 43 Hsu IC, Metcalf RA, Sun T, Welsh JA, Wang NJ, Harris CC. Mutational hotspop in the p53 gene in human hepatocellular carcinomas. Nature 1991 ; 350 : 427-8
44. 44 Hayward NK, Walker GJ, Graham W, Cooksley E. Hepatocellular carcinoma mutation. Nature 1991 ; 352 : 764
45. 45 De Souza AT, Hankins GR, Washington MK. Orton TC, Jirtle RL. M6P/IGF2R gene is mutated in human hepatocellular carcinomas with loss of heterozygosity. Natl Genet 1995 ; 11 : 447-9
46. 46 Slagle BL, Zhou YZ, Birchmeier W, Scorsone KA. Deletion of the E-cadherin gene in hepatitis B virus positive Chinese hepatocellular carcinoma. Hepatology 1993 ; 18 : 757-62
47. 47 Murakami Y. Hayashi K, Hirohashi S, Sekiya T. Aberrations of the tumor suppressor p53 and retinoblastoma genes in human hepatocellular carcinomas. Cancer Res 1991 ; 51 : 5520-5
48. 48 Vitvitski-Trepo L, Kay A, Pichoud C, Chevallier P, DeDinechin S, Shamoon BM et al. Early and frequent detection of HBxAg and/or anti-HBxAg in hepatitis B virus infection. Hepatology 1990 ; 12 : 1278-83
49. 49 Moriarty AM, Alexander H, Lerner RA. Antibodies to peptides detect new hepatitis B antigen : serological correlation with hepatocellular carcinoma. Science 1985 ; 227 : 429-33
50. 50 Kay A. Mandart E, Trépo C, Galibert F. The HBV HBx gene expressed in E coli is recognised by sera from hepatitis patients. EMBO J 1985 ; 4 : 1287-92
51. 51 Levrero M, Stemler M, Pasquinelli C, Alberti A, Jean-Jean O, Franco A et al. Significance of anti-HBx antibodies in hepatitis B virus infection. Hepatologv 1991 ; 13 : 143-9
52. 52 Henkler F, Waseem N, Golding MHC, Alison MR, Koshy R. Mutant p53 but not hepatitis B virus X protein is present in hepatitis B virus-related human hepatocellular carcinoma. Cancer Res 1995 ; 55 : 6084-91
53. 53 Dandri M, Schirmacher P, Rogler CE. Woodchuck hepatitis virus X protein is present in chronically infected woodchuck liver and in woodchuck hepatocellular carcinomas which are permissive for viral replication. J Virol 1996 ; 70 : 5246-54
54. 54 Paterlini P, Poussin K, Kew M, Franco D, Bréchot C. Selective accumulation of the X transcript of hepatitis B virus in patients negative for hepatitis B surface antigen with hepatocellular carcinoma. Hepatology 1995 ; 21 : 313-21
55. 55 Twu JS. Schloemer RH. Transcriptional trans-activating function of hepatitis B virus. J Virol 1987 ; 61 : 3448-53
56. 56 Spandau DF, Lee CH. Trans-activation of viral enhancers by the hepatitis B virus X protein. J Virol 1988 ; 62 : 427-34
57. 57 Yaginuma K, Shirakata Y, Kobayashi M, Koike K. Hepatitis B virus (HBV) particles are produced in a cell culture system by transient expression of transfected HBV DNA. Proc Natl Acad Sci 1987 ; 84 : 2678-82
58. 58 Wang W, London WT, Lega L, Feitelson MA. HBxAg in the liver from carrier patients with chronic hepatitis and cirrhosis, Hepatology 1991 ; 14 : 29-37
59. 59 Doria M, Klein N, Lucito R, Schneider RJ. The hepatitis B virus HBx protein is a dual specificity cytoplasmic activator of Ras and nuclear activator of transcription factors. EMBO J 1995 ; 14 : 4747-57
60. 60 Maguire HF, Hoeffler JP, Siddiqui A. HBV X protein alters the DNA binding specificity of CREB and ATF-2 by protein-protein interactions. Science 1991 ; 252 : 842-4
61. 61 Cheong J, Yi M, Lin Y, Murakami S. Human RPB5, a subunit shared by eukaryotic nuclear RNA polymerases, binds human Hepatitis B Virus X protein and may play a role in X transactivation. EMBO 1995 ; 14 : 143-50
62. 62 Haviv I, Vaizel D, Shaul Y. The X protein of hepatitis B virus coactivates potent activation domains. Mol Cell Biol 1995 ; 15 : 1079-85
63. 63 Haviv I, Vaizel D, Shaul Y, pX, the HBV-encoded coactivalor, interacts with components of the transcription machinery and stimulates transcription in a TAF-independent manner. EMBO J 1996 ; 15 : 3413-20
64. 64 Qadri I, Maguire HF, Siddiqui A. Hepatitis B virus trans-activator protein X interacts with the TATA-binding protein. Proc Natl Acad Sci USA 1995 ; 92 : 1003-7
65. 65 Benn J, Scheider J. Hepatitis B Virus HBx protein activates Ras-GTP complex formation and establishes a Ras, Raf, MAP kinase signaling cascade. Proc Natl Acad Sci USA 1994 ; 91 : 10350-4
66. 66 Benn J, Su F, Doria M, Schneider RJ. Hepatitis B virus HBx protein induces transcription factor AP-1 by activation of extracellular signal-regulated and c-jun N-terminal mitogen-activated protein kinases. J Virol 1996 ; 70 : 4978-85
67. 67 Kekulé AS. Lauer U, Weiss L, Luber B, Hofschneider PH. Hepatitis B virus transactivator HBx uses a tumour promoter signalling pathway. Nature 1993 ; 361 : 742-5
68. 68 Natoli G, Avantaggiati ML, Chirillo P, Puri PL, lanni A, Balsano C et al. Ras and Raf-dependent activation of c-Jun transcriptional activity by the hepatitis B virus trans-activator pX. Oncogene 1994 ; 9 : 2837-43
69. 69 Feitelson MA, Zhu M, Duan LX, London WT. Hepatitis B x antigen and p53 are associated in vitro and in liver tissues from patients with primary hepatocellular carcinoma. Oncogene 1993 ; 8 : 1109-17
70. 70 Wang XW, Forrester K, Yeh H, Feitelson MA, Gu JR, Harris CC. Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity. and association with transcription factor ERCC3. Proc Natl Acad Sci USA 1994 ; 91 : 2230-4
71. 71 Truant R, Antunovic J, Greenblatt J, Prives C, Cromlish JA. Direct interaction of the hepatitis B virus HBx protein with p53 leads to inhibition of p53 response element-directed transactivation. J Virol 1995 ; 69 : 1951-9
72. 72 Puisieux A, Ji J, Guillot C, Legros Y, Soussi T. Isselbacher K et al. p53-mediated cellular response to DNA damage in cells with replicative hepatitis B virus. Proc Natl Acad Sci USA 1995 ; 92 : 1342-6
73. 73 Chirillo P, Pagano S, Natoli G, Puri PL, Burgio VL, Balsano C et al. The hepatitis B virus X gene induces p53-mediated programmed cell death. Proc Natl Acad Sci USA 1997 ; 94 : 8162
74. 74 Greenblat MS, Feitelson MA, Zhu M, Bennet WP, Welsh JA, Jones R et al. Integrity of p53 in hepatitis B x antigen-positive and negative hepatocellular carcinoma. Cancer Res 1997 ; 57 : 426-32
75. 75 Lee TH, Elledge SJ, Butel JS. Hepatitis B virus X protein interacts with a probable DNA repair protein. J Virol 1995 ; 69 : 1107-14
76. 76 Sitterlin D, Lee TH, Prigent S, Tiollais P, Butel JS, Transy C. Interaction of the UV-damaged DNA-binding protein with hepatitis B virus X protein is conserved among mammalian hepadnaviruses and restricted to transaclivationproficient X-insertion mutants. J Virol 1997 ; 71 : 6194-9
77. 77 Huang J, Kwang J, Sun E, Liang TJ, Proteasome complex as a potential target of hepatitis B virus X protein. J Virol 1996 ; 70 : 5582-91
78. 78 Sirma H, Weil R, Rosmorduc O, Urban S, Israel A, Kremsdorf D et al. Cytosol is the prime compartment of hepatitis B virus protein where it colocalizes with the proteasome. Oncogene 1997 in press
79. 79 Lee TH, Finegold MJ, Shen RF, DeMayo JL, Woo SLC, Butel JS. Hepatitis B virus transactivator X protein is not tumorigenic in transgenic mice. J Virol 1990 ; 64 : 5939-47
80. 80 Billet O, Grimber G, Levrero M, Seye KA, Briand P, Joulin V. In vivo activity of the hepatitis B virus core promoter : tissue specificity and temporal regulation. J Virol 1995 ; 69 : 5912-6
81. 81 Slagle BL, Lee TH, Medina D, Finegold MJ, Butel JS. Increased sensitivity to the hepatocarcinogen diethylnitrosamine in transgenic mice carrying the hepatitis B virus x gene. Mol Carcinogenesis 1996 ; 15 : 261-9
82. 82 Terradillos O, Billet O, Renard CA, Levy R, Molina T, Briand P, Buendia MA. The hepatitis B virus X gene potentiates c-myc-induced liver oncogenesis in transgenic mice. Oncogene 1997 ; 14 : 395-404
83. 83 Su F, Schneider RJ. Hepatitis b virus HBx protein sensitizes cells to apoptotic killing by tumor necrosis alpha. Proc Natl Acad Sci USA 1997 ; 94 : 8744-9